Effective Treatment of Staphylococcal Enterotoxin B Aerosol Intoxication in Rhesus Macaques by Using Two Parenterally Administered High-Affinity Monoclonal Antibodies
Verreault D, Ennis J, Whaley K, Killeen SZ, Karauzum H,
Structural basis of broad ebolavirus neutralization by a human survivor antibody
West BR, Wec AZ, Moyer CL, Fusco ML, Ilinykh PA,
TBA225, a fusion toxoid vaccine for protection and broad neutralization of staphylococcal superantigens
Venkatasubramaniam A, Adhikari RP, Kort T, Liao GC, Conley S,
IBT Receives Phase I SBIR grant from NIAID for development of monoclonal antibodies against Marburg Virus using a novel discovery platform
IBT in collaboration with the laboratory of Dr. Brandon Dekosky,
IBT Receives Phase I SBIR grant from NIAID for development of monoclonal antibodies against Marburg Virus using a novel discovery platform
IBT in collaboration with the laboratory of Dr. Brandon Dekosky,
IBT Receives Phase I/II Fast Track SBIR grant from NIAID for development of broadly protective monoclonal antibodies against Influenza Virus
IBT in collaboration with Abviro, LLC (Bethesda, MD) received a
IBT Receives Phase I SBIR grant from NIAID for development of Novel ISTAb therapeutics for Staph aureus
IBT in collaboration with Dr. Jean Lee lab at Brigham
IBT Receives Phase I SBIR grant from NIAID for development of monoclonal antibodies against Marburg Virus using a novel discovery platform
IBT in collaboration with the laboratory of Dr. Brandon Dekosky,
IBT Receives Phase I/II Fast Track SBIR grant from NIAID for development of broadly protective monoclonal antibodies against Influenza Virus
IBT in collaboration with Abviro, LLC (Bethesda, MD) received a
IBT Receives Phase I SBIR grant from NIAID for development of Novel ISTAb therapeutics for Staph aureus
IBT in collaboration with Dr. Jean Lee lab at Brigham
